Professional Documents
Culture Documents
Figure 1. (a) Conceptual scheme of a hybrid lab-on-a-chip (LOC) device made of patterned polycarbonate (PC) sheet for urinalysis, (b) urine
solution inside a cup, and (c and d) its operational steps. (c) Finger force is applied to initiate negative pressure to move sample solution into the
LOC device chamber, and (d) the solution flows into the device chamber to react with the reagent pads.
facilitates rapid quantification of the smartphone camera- glucose, protein, pH, and RBC, the most common urine
captured image of the liquid analyte. analytes, have been considered using the hybrid LOC device
In the conventional dipstick method, the dipping of a strip shown in conceptual view in Figure 1, parts a and b. The device
sensor in a bottle of urine could not control the reaction accommodates a paper-based reagent strip embedded into the
volume and results in the time-dependent variation for the microchannel of a polycarbonate (PC) plastic-material-made
colorimetric assessment of the conventional test strip. To LOC device. The device used for the experiment was designed
address the issues experienced in the conventional method, this as a single microfluidic channel structure with a single inlet for
work demonstrates a cost-effective, single-channel hybrid LOC drawing sample solution into the device reaction chamber and
device integrated with an on-chip poly(dimethylsiloxane) an outlet connected to an elastic PDMS micropump. The
(PDMS) micropump for analyzing artificial urine analytes, disposable PDMS micropump, which is outlined in Figure 1c,
such as, glucose, protein, pH, and red blood cells (RBC), the initiates negative pressure inside the microchannel of the
most common urine analytes reported for a number of diseases. device, to demonstrate the flow of sample analyte for reaction
In the formation, an array of commercial paper-based reagent with the embedded reagent pads. When a finger is pressed onto
test pads was embedded across the microchannel of a plastic- the PDMS micropump, shrinking of the PDMS pump
made microfluidic device to form a paper and plastic based compresses the unoccupied zone under the pump, and the
hybrid LOC device. Since the microchannel working as reaction LOC device inlet is dipped into a sample solution container, as
chamber has a predefined volume, it contained the specific in Figure 1b. When the finger is released, as shown in Figure
volume of urine sample. So, in every measurement, the certain 1d, negative pressure originated inside the microchannel of the
volume of sample reacted with the test pads. The micropump device drives the sample analytes through the LOC micro-
integrated with the LOC device enables the loading of sample channel that serves as a reaction chamber. Eventually, the
volume into the microchannel. Since the accuracy of the smartphone camera senses the colorimetric change of the
colorimetric measurement is conceivably influenced by the reagent pads that have reacted with the analytes.
optical uniformity during image processing,25,30,35 an imaging Optical Platform. The proposed hybrid LOC platform can
box made of white acrylic poly(methyl methacrylate) (PMMA) be utilized for the analysis of equal and controlled volume of
sheet, reported previously by our group,18 has been integrated sample, fixing the test pads positions in a specific location for
with the developed platform. The imaging box including PDMS image processing. Since image processing using a smartphone
light diffuser evenly distributes the camera flash, while camera is largely affected by the color rendering index (CRI)
maintaining a consistent distance between the camera lens
values, uniform light needs to be provided.36,37 Hence, the
and target reagent pads.
■
diagnostic LOC platform includes an imaging box of white
acrylic PMMA sheet, which is equipped with a light diffuser, as
PRINCIPLES BEHIND THE DEVELOPED DEVICE, previously described.18 The imaging box provides a reprodu-
OPTICAL PLATFORM, AND COLORIMETRIC cible test platform by unifying the ambient lighting conditions.
ANALYSIS When the image of the test pads is captured inside the white
Device Principle. In conventional urinalysis, since the box under the flashlight, the flashlight transmitted through the
sensitivity of the colorimetric analysis relies on the homoge- diffuser equally disperses on the test pads, and also the light
neity of color of the urine analyte reacted reagent pads, the reflects from the white acrylic surface, thereby reducing the loss
accuracy in quantitative analysis has always been an inclusive of illumination, to avoid optical variations during image
issue. For simple and quantitative colorimetric urinalysis, processing.
13161 DOI: 10.1021/acs.analchem.7b02612
Anal. Chem. 2017, 89, 13160−13166
Analytical Chemistry Article
■
laser cutter (C30, Coryart Inc., Korea), and also, four reaction
chambers of 5 mm2 area with a depth of 2 mm for the
MATERIALS AND METHODS accommodation of reagent pads were patterned across the
Sample Preparation. “URiSCAN” reagent strips provided microchannel as in Figure 2a. Subsequently, the PC substrate
by YD-Diagnosis, Korea were used to fabricate the hybrid with patterned channel was thermally bonded on the blank PC
microfluidic LOC device for urinalysis. The chemicals for the substrate to form the microfluidic channel using a hot press
preparation of the artificial urine specimen were dextrose with applied pressure of 2.5 bar at 140 °C for 10 min, and an
powder (Streck, U.S.A.), albumin solution (Comscience Ltd., outlet hole of 1 mm diameter was drilled in the blank PC
Korea), and pH buffer solutions (Samchun, Korea). Urinary substrate.
solutions of glucose and protein of different concentrations To prepare the disposable hybrid LOC platform, the reagent
were prepared using DI water; solution of different RBCs/μL of strip including four different reagent pads as sensing area was
sample, which was collected from a healthy donor in a hospital attached to the microfluidic channel of the LOC device through
following the local regulations, was prepared using phosphate the vacant sidewall of the device, and the sidewall was then
buffer saline (PBS). The concentrations associated with the sealed with epoxy polymer. The elastic PDMS micropump was
analysis were 0−350 mg/dL for glucose, 0−2000 mg/dL for fabricated by replica molding technique as reported pre-
protein, 5.25−7.5 for pH, and 0−280 RBC/μL of solution for viously39 and attached to the outlet of the LOC device, as
red blood cells, which are in the typical physiological ranges shown in Figure 2a, to load sample inside the microchannel.
found in actual urine for a wide variety of screening issues. The standard elasticity of the PDMS micropump was
These concentrations of glucose, protein, and RBC were confirmed by the mixing ratio of curing agent and Sylgard
obtained through serial dilution of their standard solutions. 184 (Dupont Inc., U.S.A.) of 1:14 and pouring the PDMS
Device Fabrication. The hybrid POC testing platform mixture into a hemispherical mold, which was then cured at 70
developed for urinalysis comprises (i) an array of commercial °C for 4 h and shaped accordingly to prepare the micropump.
URiSCAN reagent test pads embedded across the micro- The fixation of the paper-based four reagent test pads into the
channel of the microfluidic hybrid LOC device, (ii) a white LOC device provides a number of measurement facilities over
acrylic imaging box, and (iii) a smartphone with the developed the conventional dipstick methods, which have been
Android “UrineAnalysis” app for the analysis of captured image summarized as Table S1 in the Supporting Information.
of the colorimetric test strip inside the microchannel of the The finger pressing and releasing from the PDMS micro-
LOC device. pump that involve the flow of artificial urine analytes through
To fabricate the LOC device for urine analysis, the the device microchannel, as described in the Device Principle
technologically sensitive lithography process has been replaced section, are shown in Figure 2b. Figure 2c shows a smartphone
by a low-cost hot-embossing technique (Qmesys Corp., Korea), on the top of the white acrylic imaging box for imaging of the
using a laser cutter (C30, Coryart Inc., Korea) for patterning of LOC device. While the urine analytes interact with test strip
the microchannel of the device. Figure 2a demonstrates the inside the microchannel, and colorimetric changes occur in the
fabricated LOC device of 70 mm × 20 mm × 4 mm (length × reagent pads, the LOC device is positioned inside the imaging
13162 DOI: 10.1021/acs.analchem.7b02612
Anal. Chem. 2017, 89, 13160−13166
Analytical Chemistry Article
Figure 3. Measurement of hue value (a) varying the reaction time of the test strip into glucose solution of 50 mg/dL and (b) varying the removal
time of solution from the test strip while taking out from the glucose solution of 50 mg/dL in the conventional dipstick method.
Figure 4. Measurement of hue value with respect to sample volume of (a) 50 mg/dL glucose, (b) 300 mg/dL protein, (c) pH 5.5, and (d) 150
RBC/μL of solution using the developed LOC device.
box using a sample holder as shown in Figure 2d for imaging been embedded into the LOC chip, includes test pads for the
with the smartphone. measurement of urinary glucose, protein, pH, and RBC.
Image Acquisition and Colorimetric Analysis of the Limitations of Conventional Dipstick-Based Urinaly-
Image Using the Developed App. To quantify the hue sis. Conventionally, urinalysis using the URiSCAN dipstick is
value from the colorimetric reaction, the LOC device including executed by exposing the dipstick reagent pad inside the urine
the test pads is placed inside the imaging box, as in Figure 2d. solution, and clinical diagnosis is interpreted based on the visual
Then, a smartphone placed on top of the box captures the colorimetric change of the reagent pads. The test method
image of the test pads, and the “UrineAnalysis” Android app suggests (i) dipping the test strip for 1 s inside the urine
processes the images to extract the colorimetric information as solution, (ii) removing the leftover solution from the strip using
hue value following the functional steps as given in Figure S2 of soft tissue when the strip is taken out of the solution, and (iii)
the Supporting Information. then leaving the strip for 1 min, referred to as the reaction time,
Figure 6. Measurement of the hue value for (a) glucose, (b) protein, (c) pH, and (d) RBC of different concentrations.
■
design complicated LED arrays and highly priced external
lenses for the colorimetric analysis of urine assays. The AUTHOR INFORMATION
dimension of the white-acrylic-made optical box is phone-
Corresponding Author
specific to fix the optimal distance between the smartphone *Phone: +82-10-4121-3075. E-mail: shim@kw.ac.kr.
camera and target sample that could be revised with minimal
ORCID
redesigning for different specifications of the smartphones. Uddin M. Jalal: 0000-0003-2533-8019
■ CONCLUSIONS
Notes
The authors declare no competing financial interest.
In this work, a unique low-priced hybrid microfluidic LOC
device combined with a smartphone-based optical platform has
been proposed for the colorimetric detection of urinary
■ ACKNOWLEDGMENTS
The authors gratefully acknowledge the support for this work
biomarkers. The hybrid device successfully demonstrated the from a Kwangwoon Research Grant of 2017. This research was
precisely controlled volume of sample solution for a fixed also partly supported by the Technological Innovation R&D
program of the SMBA (S2498668) and the Basic Science
colorimetric reaction time inside the device microchannel,
Research Program through the National Research Foundation
thereby reducing time-dependent measurement inaccuracy. of Korea (NRF), funded by the Ministry of Education (no.
The utilization of the smartphone app as an optical reader NRF-2015R1D1A1A01060369).
and image processor made the colorimetric urinalysis
convenient, reducing the observer and measurement variability
that arise in the typical colorimetric POC diagnosis. Thus, the
■ REFERENCES
(1) Coppens, A.; Speeckaert, M.; Delanghe, J. Acta. Clin. Belg. 2010,
developed smartphone-based hybrid LOC platform can be 65, 182−189.
(2) Devillé, W. L. J. M.; Yzermans, J. C.; van Duijn, N. P.; Bezemer,
widely applicable for other colorimetric assays in clinical P. D.; van der Windt, D. A.; Bouter, L. M. BMC Urol. 2004, 4 (1), 4−
applications. 17.
(3) Kanegaye, K. T.; Jacob, J. M.; Malicki, D. Pediatrics 2014, 134 (35) García, A.; Erenas, M. M.; Marinetto, E. D.; Abad, C. A.; de
(3), 523−529. Orbe-Paya, I.; Palma, A. J.; Capitan-Vallvey, L. F. Sens. Actuators, B
(4) Simerville, J. A.; Maxted, W. C.; Pahira, J. J. Am. Fam. Physician. 2011, 156, 350−359.
2005, 71 (6), 1153−1162. (36) Lopez-Ruiz, N.; Curto, V. F.; Erenas, M. M.; Benito-Lopez, F.;
(5) McPherson, R. A.; Pincus, M. R. Henry’s Clinical Diagnosis and Diamond, D.; Palma, A. J.; Capitan-Vallvey, L. F. Anal. Chem. 2014,
Management by Laboratory Method; Elsevier/Saunders: Philadelphia, 86, 9554−62.
PA, 2011. (37) Wang, R.; Prabhakar, A.; Iglesias, R. A.; Xian, X.; Shan, X.;
(6) Chenari, M. R.; Gooran, S.; Zarghami, A.; Fazeli, F. OJU 2012, 2, Tsow, F.; Forzani, E. S.; Tao, N. IEEE Sens. J. 2012, 12, 1529−1535.
227−231. (38) Murdock, R. C.; Shen, L.; Griffin, D. K.; Kelley-Loughnane, N.;
(7) Abirami, K.; Tiwari, S. C. J. Ind. Acad. Clin. Med. 2001, 2 (1), 39− Papautsky, I.; Hagen, J. A. Anal. Chem. 2013, 85, 11634−11642.
50. (39) Lee, H. C. Introduction to Color Imaging Science; Cambridge
(8) Delanghe, J.; Speeckaert, M. Biochemia. Medica. 2014, 24 (1), University Press: Cambridge, U.K., 2005.
89−104. (40) Oncescu, V.; O’Dell, D.; Erickson, D. Lab Chip 2013, 13, 3232−
(9) Ko, K.; Kwon, M.-J.; Ryu, S.; Woo, H.-T.; Park, H. J. Clin. Lab. 38.
Anal. 2016, 30 (5), 424−430. (41) Chang, B. Y. Bull. Korean Chem. Soc. 2012, 33, 549−52.
(10) Pugia, M. J. Lab. Med. 2000, 31 (2), 92−96. (42) Cantrell, K.; Erenas, M. M.; de Orbe-Payá, I.; Capitán-Vallvey,
(11) Mundt, L. A.; Shanahan, K. Graff’s Textbook of Routine Urinalysis L. F. Anal. Chem. 2010, 82 (2), 531−542.
and Body Fluids; Wolters Kluwer/Lippincott Williams & Wilkins (43) Khan, M.; Jamil, A.; Haleem, F.; Muhammad, Z. A. Middle-East
Health: Philadelphia, PA, 2016. J. Sci. Res. 2014, 22 (5), 647−654.
(12) Hong, J. I.; Chang, B. Y. Lab Chip 2014, 14, 1725−1732. (44) Marshall, W. J.; Bangert, S. K. Clinical Biochemistry: Metabolic
(13) Memişoğullar, R.; Yüksel, H.; Yildirim, H. A.; Yavuz, Ö . Eur. J. and Clinical Aspects; Churchill Livingstone: Edinburgh, U.K., 1995.
(45) Kim, H.; Awofeso, O.; Choi, S.; Jung, Y.; Bae, E. Appl. Opt.
Gen. Med. 2010, 7 (2), 174−178.
2017, 56 (1), 84−92.
(14) De Silva, D. A.; Halstead, A. C.; Côté, A. M.; Sabr, Y.; von
(46) Im, S. B.; Kim, S. C.; Shim, J. S. Anal. Bioanal. Chem. 2016, 408,
Dadelszen, P.; Magee, L. A. J. Obstet. Gynaecol. Can. 2014, 36 (7),
1391−1397.
605−612. (47) Vashist, S. K.; Luppa, P. B.; Yeo, L. Y.; Ozcan, A.; Luong, J. H.
(15) Langlois, M. R.; Delanghe, J. R.; Steyaert, S. R.; Everaert, K. C.; T. Trends Biotechnol. 2015, 33, 692−705.
De Buyzere, M. L. Clin. Chem. 1999, 45 (1), 118−122. (48) Mudanyali, O.; Dimitrov, S.; Sikora, U.; Padmanabhan, S.;
(16) Jeong, S. G.; Kim, J.; Nam, J. O.; Song, Y. S.; Lee, C. S. Int. Navruz, I.; Ozcan, A. Lab Chip 2012, 12, 2678−2686.
Neurourol. J. 2013, 17 (4), 155−161. (49) Dutta, S.; Sarma, D.; Patel, A.; Nath, P. IEEE Photonics Technol.
(17) Lee, D.-S.; Jeon, B. G.; Ihm, C.; Park, J.-K. Lab Chip 2011, 11, Lett. 2015, 27 (22), 2363−2366.
120−126. (50) Dutta, S.; Saikia, K.; Nath, P. RSC Adv. 2016, 6, 21871−21880.
(18) Kim, S. C.; Jalal, U. M.; Im, S. B.; Ko, S.; Shim, J. S. Sens. (51) Kim, S. D.; Koo, Y.; Yun, Y. Sensors 2017, 17, 1604.
Actuators, B 2017, 239, 52−59.
(19) Chen, A.; Wang, R.; Bever, C. R. S.; Xing, S.; Hammock, B. D.;
Pan, T. Biomicrofluidics 2014, 8, 064101−064111.
(20) Barbosa, A. I.; Gehlot, P.; Sidapra, K.; Edwards, A. D.; Reis, N.
M. Biosens. Bioelectron. 2015, 70, 5−14.
(21) Roda, A.; Michelini, E.; Cevenini, L.; Calabria, D.; Calabretta,
M. M.; Simoni, P. Anal. Chem. 2014, 86, 7299−7304.
(22) You, D. J.; Park, T. S.; Yoon, J.-Y. Biosens. Bioelectron. 2013, 40,
180−185.
(23) Kim, S.; Cho, D.; Kim, J.; Kim, M.; Youn, S.; Jang, J. E.; Je, M.;
Lee, D. H.; Lee, B.; Farkas, D. L.; Hwang, J. Y. Biomed. Opt. Express
2016, 7 (12), 5294−5307.
(24) Pierce, M. C.; Weigum, S. E.; Jaslove, J. M.; Richards-Kortum,
R.; Tkaczyk, T. S. Ann. Biomed. Eng. 2014, 42, 231−240.
(25) Shen, L.; Hagen, J. A.; Papautsky, I. Lab Chip 2012, 12, 4240−
4243.
(26) Weigl, B.; Domingo, G.; Labarre, P.; Gerlach, J. Lab Chip 2008,
8 (12), 1999−2014.
(27) Zhu, H.; Isikman, S. O.; Mudanyali, O.; Greenbaum, A.; Ozcan,
A. Lab Chip 2013, 13, 51−67.
(28) Jalal, U. M.; Kim, S. C.; Shim, J. S. Biomed. Opt. Express 2017, 8
(7), 3317−3328.
(29) Vashist, S. K.; van Oordt, T.; Schneider, E. M.; Zengerle, R.; von
Stetten, F.; Luong, J. H. T. Biosens. Bioelectron. 2015, 67, 248−255.
(30) Yetisen, A. K.; Martinez-Hurtado, J. L.; Garcia-Melendrez, A.; da
Cruz Vasconcellos, F.; Lowe, C. R. Sens. Actuators, B 2014, 196, 156−
160.
(31) Lee, S.; Oncescu, V.; Mancuso, M.; Mehta, S.; Erickson, D. Lab
Chip 2014, 14, 1437−1442.
(32) Koesdjojo, M. T.; Pengpumkiat, S.; Wu, Y.; Boonloed, A.;
Huynh, D.; Remcho, T. P.; Remcho, V. T. J. Chem. Educ. 2015, 92 (4),
737−741.
(33) Jung, Y.; Kim, J.; Awofeso, O.; Kim, H.; Regnier, F.; Bae, E.
Appl. Opt. 2015, 54 (31), 9183−9189.
(34) Wang, Y.; Li, Y.; Bao, X.; Han, J.; Xia, J.; Tian, X.; Ni, L. Talanta
2016, 160, 194−204.